[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-detail-334620-en":59,"doc-seo-334620-105":81},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":5,"data":60},{"doc_id":61,"user_id":62,"nickname":63,"user_avatar":64,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":66,"doc_content":67,"file_id":68,"file_url":69,"file_type":70,"file_size":71,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":72,"language":73,"language_code":74,"site_id":75,"html_lang":74,"table_of_contents":76,"faqs":77,"seo_title":78,"seo_description":66,"update_tm":79,"read_time":80,"preview_page_count":4},334620,34359740700684,"Finn","https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","Somatic mutations in four novel genes contribute to homologous recombination deficiency in breast cancer: a real-world clinical tumor sequencing study","Breast cancers that harbor mutations in homologous recombination (HR) genes, especially BRCA1/2, show strong responses to PARP inhibitors and platinum-based chemotherapy. Beyond BRCA1/2 and PLAB2, the additional somatic alterations driving homologous recombination deficiency (HRD) remain unclear. This study applied next-generation sequencing to tumor tissues and matched blood from 119 patients, analyzed mutation profiles and HRD scores, and identified LNGC gene mutations linked to high HRD and PARP inhibitor sensitivity.","The Journal of Pathology: Clinical Research J Pathol Clin Res March 2024; 10: e12367 Published online in Wiley Online Library (wi[leyonlinelibrary.com](leyonlinelibrary.com). DOI: 10.1002/2056-4538.12367)[).](leyonlinelibrary.com). DOI: 10.1002/2056-4538.12367)[ DOI: 10.1002/2056-4538.12367](leyonlinelibrary.com). DOI: 10.1002/2056-4538.12367)  \nORIGINAL ARTICLE  \nSomatic mutations in four novel genes contribute to homologous recombination deﬁciency in breast cancer: a real-world clinical tumor sequencing study  \nYongsheng Huang 1,2† , Yuntan Qiu2†, Linxiaoxiao Ding3†, Shuwei Ren4†, Yuanling Jiang 1 , Jiahuan Luo 1 , Jinghua Huang 1 , Xinke Yin 1 , Sha Fu 1 *, Jianli Zhao3,5*, Kaishun Hu2* and Jianwei Liao 1 *  \n1 Cellular & Molecular Diagnostics Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, PR China 2Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangzhou, PR China 3Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, PR China  \n4Department of Clinical Laboratory, The Sixth Afﬁliated Hospital, Sun Yat-sen University, Guangzhou, PR China  \n5Guangzhou Regenerative Medicine and Health, Guangdong Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, PR China  \n*Correspondence to: Sha Fu, Cellular & Molecular Diagnostics Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 33 Ying Feng Road, Guangzhou 510120, PR China. E-mail: [fush6@mail.sysu.edu.cn](fush6@mail.sysu.edu.cn); Jianli Zhao, Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University; Guangzhou Regenerative Medicine and Health, Guangdong Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 33 Ying Feng Road, Guangzhou 510120, [PR China. E-mail:](PR China. E-mail: zhaojli5@mail.sysu.edu.cn)[ zhaojli5@mail.sysu.edu.cn](PR China. E-mail: zhaojli5@mail.sysu.edu.cn); Kaishun Hu, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, 107 Yanjiang West Road, Guangzhou 510120, PR China. E-mail: [huksh3@mail.sysu.edu.cn](huksh3@mail.sysu.edu.cn); Jianwei Liao, Cellular & Molecular Diagnostics Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 33 Ying Feng Road, Guangzhou  \n510120, PR China. E-mail: [liaojw8@mail.sysu.edu.cn](liaojw8@mail.sysu.edu.cn)  \n†These authors contributed equally to this work.  \nAbstract  \nBreast cancers involving mutations in homologous recombination (HR) genes, most commonly BRCA1 and BRCA2 (BRCA1/2), respond well to PARP inhibitors and platinum-based chemotherapy. However, except for these speciﬁc HR genes, it is not clear which other mutations contribute to homologous recombination defects (HRD). Here, we performed next-generation sequencing of tumor tissues and matched blood samples from 119 breast cancer patients using the OncoScreen Plus panel. Genomic mutation characteristics and HRD scores were analyzed. In the HR genes, we found that BRCA1/2 and PLAB2 mutations were related to HRD. HRD was also detected in a subset of patients without germline or somatic mutations in BRCA1/2, PLAB2, or other HR-related genes. Notably, LRP1B, NOTCH3, GATA2, and CARD11 (abbreviated as LNGC) mutations were associated with high HRD scores in breast cancer patients. Furthermore, functional experiments demonstrated that silencing CARD11 and GATA2 impairs HR repair efﬁciency and enhances the sensitivity of tumor cells to olaparib treatment. In summary, in the absence of mutations in the HR genes, the sensitivity of tumor cells to PARP inhibitors and platinum-based chemotherapy maybe enhanced in a subset of breast cancer patients with LNGC somatic mutations.  \nKeywords: homologous recombination; next-generation sequencing; breast cancer  \nReceived 8 August 2023; Revised 31 January 2024; Accepted 13 February 2024 No conﬂicts of interest were declared.  \nIntroduction  \nMutations in BRCA1 and BRCA2 (BRCA1/2), the essential components of the homologous recombinat","cbCaioUf5ovLFl6j","https://ap.wps.com/l/cbCaioUf5ovLFl6j","pdf",7766945,13,"English","en",105,"# Introduction\n## HRD, BRCA1/2, and clinical relevance of PARP inhibitors\n# Abstract\n## Study design and findings on novel HRD-associated genes\n# Keywords\n## Core terms: HR, NGS, and breast cancer","[{\"question\":\"Which gene mutations were found to be associated with homologous recombination deficiency (HRD)?\",\"answer\":\"BRCA1/2 and PLAB2 mutations were related to HRD. In addition, mutations in LRP1B, NOTCH3, GATA2, and CARD11 (LNGC) were associated with high HRD scores in breast cancer patients.\"},{\"question\":\"How was HRD evaluated in the study?\",\"answer\":\"Tumor tissues and matched blood samples from 119 patients were analyzed by next-generation sequencing using the OncoScreen Plus panel, followed by analysis of genomic mutation characteristics and HRD scores.\"},{\"question\":\"What functional evidence supports the role of LNGC mutations in therapy sensitivity?\",\"answer\":\"Silencing CARD11 and GATA2 reduced HR repair efficiency and increased sensitivity of tumor cells to olaparib, supporting a mechanistic link between these mutations and treatment response.\"}]","Somatic mutations in four novel genes contribute to homologous recombination deficiency in breast cancer: a real-world clinical tumor sequencing study | PDF",1790007520,33,{"code":4,"msg":82,"data":83},"ok",{"site_id":75,"language":74,"slug":84,"title":65,"keywords":85,"description":66,"schema_data":86,"social_meta":140,"head_meta":142,"extra_data":144,"updated_unix":145},"somatic-mutations-in-four-novel-genes-contribute-to-homologous-recombination-deficiency-in-breast-cancer-a-real-world-clinical-tumor-sequencing-study","",{"@graph":87,"@context":139},[88,102,122],{"@type":89,"itemListElement":90},"BreadcrumbList",[91,95,97,100],{"item":92,"name":93,"@type":94,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":96,"name":9,"@type":94,"position":14},"https://docshare.wps.com/document/",{"item":98,"name":40,"@type":94,"position":99},"https://docshare.wps.com/document/research-report/",3,{"item":101,"name":65,"@type":94,"position":19},"https://docshare.wps.com/document/somatic-mutations-in-four-novel-genes-contribute-to-homologous-recombination-deficiency-in-breast-cancer-a-real-world-clinical-tumor-sequencing-study/334620/",{"url":101,"name":65,"@type":103,"image":104,"author":109,"headline":65,"publisher":111,"fileFormat":114,"inLanguage":74,"description":66,"dateModified":115,"datePublished":116,"encodingFormat":114,"isAccessibleForFree":117,"interactionStatistic":118},"DigitalDocument",{"url":105,"@type":106,"width":107,"height":108},"https://docshare.wps.com/thumbnails/somatic-mutations-in-four-novel-genes-contribute-to-homologous-recombination-deficiency-in-breast-cancer-a-real-world-clinical-tumor-sequencing-study/334620.png","ImageObject",300,407,{"name":63,"@type":110},"Person",{"url":92,"name":112,"@type":113},"DocShare","Organization","application/pdf","2026-10-25","2026-09-21",true,{"@type":119,"interactionType":120,"userInteractionCount":34},"InteractionCounter",{"@type":121},"ViewAction",{"@type":123,"mainEntity":124},"FAQPage",[125,131,135],{"name":126,"@type":127,"acceptedAnswer":128},"Which gene mutations were found to be associated with homologous recombination deficiency (HRD)?","Question",{"text":129,"@type":130},"BRCA1/2 and PLAB2 mutations were related to HRD. In addition, mutations in LRP1B, NOTCH3, GATA2, and CARD11 (LNGC) were associated with high HRD scores in breast cancer patients.","Answer",{"name":132,"@type":127,"acceptedAnswer":133},"How was HRD evaluated in the study?",{"text":134,"@type":130},"Tumor tissues and matched blood samples from 119 patients were analyzed by next-generation sequencing using the OncoScreen Plus panel, followed by analysis of genomic mutation characteristics and HRD scores.",{"name":136,"@type":127,"acceptedAnswer":137},"What functional evidence supports the role of LNGC mutations in therapy sensitivity?",{"text":138,"@type":130},"Silencing CARD11 and GATA2 reduced HR repair efficiency and increased sensitivity of tumor cells to olaparib, supporting a mechanistic link between these mutations and treatment response.","https://schema.org",{"og:url":101,"og:type":141,"og:title":65,"og:site_name":112,"og:description":66},"article",{"robots":143,"canonical":101},"index,follow",{"doc_id":61,"site_id":75},1790165203]